kanamycin a has been researched along with vitamin k 3 in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goswami, M; Jawali, N; Mangoli, SH | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
Cao, S; Delgado, A; Gustafson, JE; Hughes, D; LannergÄrd, J; Norström, T | 1 |
4 other study(ies) available for kanamycin a and vitamin k 3
Article | Year |
---|---|
Effects of glutathione and ascorbic acid on streptomycin sensitivity of Escherichia coli.
Topics: Anti-Bacterial Agents; Antioxidants; Ascorbic Acid; Catalase; Escherichia coli; Glutathione; Indicators and Reagents; Nitroblue Tetrazolium; Peroxidases; Peroxiredoxins; Reactive Oxygen Species; Streptomycin; Superoxide Dismutase | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Genetic complexity of fusidic acid-resistant small colony variants (SCV) in Staphylococcus aureus.
Topics: Bacterial Proteins; Colony Count, Microbial; Culture Media; Drug Resistance, Bacterial; Fusidic Acid; Hemin; Kanamycin; Microbial Sensitivity Tests; Mutation; Phenotype; Staphylococcus aureus; Vitamin K 3 | 2011 |